Gabapentin Augmentation for Fluoxetine-Treated Patients With Obsessive-Compulsive Disorder
1998; Physicians Postgraduate Press, Inc.; Volume: 59; Issue: 9 Linguagem: Inglês
10.4088/jcp.v59n0907d
ISSN1555-2101
AutoresGabriela Cora‐Locatelli, Benjamin D. Greenberg, Juliet Martin, Dennis L. Murphy,
Tópico(s)Neurotransmitter Receptor Influence on Behavior
ResumoArticle AbstractSir: Serotonin reuptake inhibitors (SRIs) are the most effective pharmacologic treatment for obsessive-compulsive disorder (OCD). However, few patients have a complete response to SRIs. Because augmentation strategies are needed, we initiated a pilot study of gabapentin in patients with OCD who had a partial or incomplete response to SRI treatment.
Referência(s)